Ondine Biomedical Inc. (AIM:OBI)

Ondine Biomedical Revenue

In the year 2025, Ondine Biomedical had annual revenue of 2.65M CAD with 29.14% growth. Ondine Biomedical had revenue of 1.63M in the half year ending December 31, 2025, with 110.71% growth.

• Revenue: 2.65M CAD
• Revenue Growth: +29.14%
• P/S Ratio: 53.45
• Revenue / Employee: 147.00K CAD
• Employees: 18
• Market Cap: 76.63M GBP

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.65M	597.00K	29.14%
Dec 31, 2024	2.05M	846.00K	70.32%
Dec 31, 2023	1.20M	565.00K	88.56%
Dec 31, 2022	638.00K	-1.93M	-75.17%
Dec 31, 2021	2.57M	778.00K	43.44%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 12, 2026

Data Sources Report a data error